Abrams Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $62.6M | Sell |
|
|||||
|
2023
Q3 | $81.3M | Hold |
|
|||||
|
2023
Q2 | $60M | Hold |
|
|||||
|
2023
Q1 | $70.5M | Sell |
|
|||||
|
2022
Q4 | $145M | Sell |
|
|||||
|
2022
Q3 | $193M | Sell |
|
|||||
|
2022
Q2 | $181M | Hold |
|
|||||
|
2022
Q1 | $226M | Hold |
|
|||||
|
2021
Q4 | $193M | Hold |
|
|||||
|
2021
Q3 | $234M | Hold |
|
|||||
|
2021
Q2 | $238M | Hold |
|
|||||
|
2021
Q1 | $277M | Hold |
|
|||||
|
2020
Q4 | $232M | Hold |
|
|||||
|
2020
Q3 | $217M | Hold |
|
|||||
|
2020
Q2 | $296M | Hold |
|
|||||
|
2020
Q1 | $216M | Hold |
|
|||||
|
2019
Q4 | $236M | Hold |
|
|||||
|
2019
Q3 | $165M | Buy |
|
|||||
|
2019
Q2 | $167M | Hold |
|
|||||
|
2019
Q1 | $283M | Sell |
|
|||||
|
2018
Q4 | $286M | Sell |
|
|||||
|
2018
Q3 | $421M | Sell |
|
|||||
|
2018
Q2 | $480M | Hold |
|
|||||
|
2018
Q1 | $337M | Hold |
|
|||||
|
2017
Q4 | $374M | Sell |
|
|||||
|
2017
Q3 | $381M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $100M | Buy |
|